Adrenal gland cancer
Results
Phase 3
This trial looked at mitotane after surgery for adrenal gland cancer. It was for people who had a small chance that the cancer could come back.
The trial was supported by Cancer Research UK. It was open in the UK for people to join between 2014 and 2017. The team presented the results at a conference in 2022.
Recruitment start: 17 April 2014
Recruitment end: 27 January 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Wiebke Arlt
Cancer Research UK
ENSAT (European Network for the Study of Adrenal Tumours)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Birmingham
This is Cancer Research UK trial number CRUK/12/018.
Last reviewed: 17 May 2022
CRUK internal database number: 9538
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
